Követés
Zsombor Zrubka
Zsombor Zrubka
E-mail megerősítve itt: uni-obuda.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Authorized manufacturing changes for therapeutic monoclonal antibodies (mAbs) in European Public Assessment Report (EPAR) documents
B Vezér, Z Buzás, M Sebeszta, Z Zrubka
Current medical research and opinion 32 (5), 829-834, 2016
1272016
Psychometric properties of the Hungarian version of the eHealth Literacy Scale
Z Zrubka, O Hajdu, F Rencz, P Baji, L Gulácsi, M Péntek
The European Journal of Health Economics 20 (1), 57-69, 2019
392019
The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys
P Baji, D Golicki, V Prevolnik-Rupel, WBF Brouwer, Z Zrubka, L Gulácsi, ...
The European Journal of Health Economics 20 (1), 5-16, 2019
302019
State of the art in adoption of contact tracing apps and recommendations regarding privacy protection and public health: Systematic review
K Kolasa, F Mazzi, E Leszczuk-Czubkowska, Z Zrubka, M Péntek
JMIR mHealth and uHealth 9 (6), e23250, 2021
252021
A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases
Z Zrubka, Z Beretzky, Z Hermann, V Brodszky, L Gulácsi, F Rencz, P Baji, ...
The European Journal of Health Economics 20 (1), 119-132, 2019
222019
The economic impact of biosimilars on chronic immune-mediated inflammatory diseases
M Pentek, Z Zrubka, L Gulacsi
Current Pharmaceutical Design 23 (44), 6770-6778, 2017
212017
Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis
Z Zrubka, L Gulácsi, V Brodszky, F Rencz, R Alten, Z Szekanecz, ...
Expert Review of Pharmacoeconomics & Outcomes Research 19 (5), 537-549, 2019
162019
Capability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data
P Baji, M Farkas, Á Dobos, Z Zrubka, L Gulácsi, V Brodszky, F Rencz, ...
Quality of Life Research 29 (10), 2863-2874, 2020
142020
Development of population tariffs for the CarerQol instrument for Hungary, Poland and Slovenia: A discrete choice experiment study to measure the burden of informal caregiving
P Baji, M Farkas, D Golicki, V Prevolnik Rupel, R Hoefman, WBF Brouwer, ...
Pharmacoeconomics 38 (6), 633-643, 2020
132020
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic markers of survival in patients with head and neck tumours—results of a retrospective multicentric study
Z Szilasi, V Jósa, Z Zrubka, T Mezei, T Vass, K Merkel, F Helfferich, ...
International Journal of Environmental Research and Public Health 17 (5), 1742, 2020
132020
Measurement and health economic evaluation of informal care [Az informális ellátás mérése és egészség-gazdaságtani értékelése]
Z Zrubka
Orv Hetil 158, 1363-1372, 2017
13*2017
Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary
M Péntek, O Hajdu, F Rencz, Z Beretzky, V Brodszky, P Baji, Z Zrubka, ...
The European Journal of Health Economics 20 (1), 17-30, 2019
122019
Exploring eHealth Literacy and patient-reported experiences with outpatient care in the Hungarian general adult population: Cross-sectional study
Z Zrubka, ÓB Fernandes, P Baji, O Hajdu, L Kovacs, D Kringos, ...
Journal of medical Internet research 22 (8), e19013, 2020
102020
Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from hungarian, polish and slovenian population studies
Z Zrubka, D Golicki, V Prevolnik-Rupel, P Baji, F Rencz, V Brodszky, ...
The European Journal of Health Economics 20 (1), 141-154, 2019
92019
Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
Z Zrubka, Z Hermann, L Gulácsi, V Brodszky, F Rencz, M Péntek
The European Journal of Health Economics 20 (1), 31-41, 2019
9*2019
Thrombocytosis and effects of IL-6 knock-out in a colitis-associated cancer model
V Josa, S Ferenczi, R Szalai, E Fuder, D Kuti, K Horvath, N Hegedus, ...
International journal of molecular sciences 21 (17), 6218, 2020
82020
EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis
Z Zrubka, F Rencz, J Zavada, D Golicki, VP Rupel, J Simon, V Brodszky, ...
Rheumatology international 37 (12), 1957-1977, 2017
82017
Economic aspects of biosimilar competition in Hungary—The treatment of rheumatic disorders
Z Zrubka
Society and Economy 39 (2), 271-290, 2017
72017
Health economic publications from the Middle East and North Africa Region: a scoping review of the volume and methods of research
Z Zrubka, O Rashdan, L Gulácsi
Global Journal on Quality and Safety in Healthcare 3 (2), 44-54, 2020
62020
Long-Term efficacy of tumor necrosis factor inhibitors for the treatment of Methotrexate-Naïve rheumatoid arthritis: systematic literature review and meta-analysis
L Gulácsi, Z Zrubka, V Brodszky, F Rencz, R Alten, Z Szekanecz, ...
Advances in Therapy 36 (3), 721-745, 2019
62019
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20